These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 23555867

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
    Pasquier E, André N, Street J, Chougule A, Rekhi B, Ghosh J, Philip DSJ, Meurer M, MacKenzie KL, Kavallaris M, Banavali SD.
    EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
    [Abstract] [Full Text] [Related]

  • 7. PropAngio study protocol: a neoadjuvant trial on the efficacy of propranolol monotherapy in cutaneous angiosarcoma-a proof of principle study.
    Heinhuis KM, IJzerman NS, Koenen AM, van der Graaf WTA, Haas RL, Beijnen JH, Huitema ADR, van Houdt WJ, Steeghs N.
    BMJ Open; 2020 Sep 10; 10(9):e039449. PubMed ID: 32912994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
    Lin X, Luo K, Lv Z, Huang J.
    Hepatogastroenterology; 2012 Sep 10; 59(114):584-8. PubMed ID: 22353526
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion.
    Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Béliveau R.
    Pharmacol Res; 2009 Nov 10; 60(5):438-45. PubMed ID: 19467330
    [Abstract] [Full Text] [Related]

  • 15. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma.
    Wolter JK, Wolter NE, Blanch A, Partridge T, Cheng L, Morgenstern DA, Podkowa M, Kaplan DR, Irwin MS.
    Oncotarget; 2014 Jan 15; 5(1):161-72. PubMed ID: 24389287
    [Abstract] [Full Text] [Related]

  • 16. Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.
    Wang F, Liu H, Wang F, Xu R, Wang P, Tang F, Zhang X, Zhu Z, Lv H, Han T.
    Mol Med Rep; 2018 Apr 15; 17(4):5213-5221. PubMed ID: 29393410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).
    Embaby A, Heinhuis KM, IJzerman NS, Koenen AM, van der Kleij S, Hofland I, van Boven H, Sanders J, van der Graaf WTA, Haas RL, Huitema ADR, van Houdt WJ, Steeghs N.
    Eur J Cancer; 2024 May 15; 202():113974. PubMed ID: 38452721
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.